RxDoctor Payments Data

Julia Tolentino, MD

Colon & Rectal Surgery · Easton, PANPI 1598147969

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (38.8%), education and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 71.9% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2021 at $1,859 and has fallen 89.7% since, to $191 in 2024. That places this record below the midpoint for colon & rectal surgery clinicians in PA, where the typical reported total is $2,089.

$2,621in general payments, 2019–2025

Across 36 payments — averaging $72.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$2K
  • Medtronic$141
  • Acell, Inc.$125
  • Merck$100
  • Integra Lifesciences Corporation$88
  • KCI USA, Inc.$57
  • plus $226 from 6 others

What the payments were for

  • Travel & lodging$60323%
  • Food & beverage$1,01839%
  • Education$1,00038%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,621 in reported general payments places this provider in the 50th percentile of 108 colon & rectal surgery providers in Pennsylvania.

See all colon & rectal surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$65,044
Medicare patients
185
Services billed
351

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Neomycin Sulfate15$63
Metronidazole18$37

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Easton

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →